The company obtained CE marking in less time thanks to Rephine’s global approach to ensure not only the development and validation of the software but also the necessary quality assurance system (QMS).
About this Case Study
The case study involved CE Mark for a new Medical Device Software. The company has developed software that is considered as a Medical Device. They must comply with the regulatory requirements and obtain the CE Mark for the
commercialisation of the new product in Europe.
To learn more about the successful project and the comprehensive results achieved in obtaining CE Mark compliance, download the full case study now.
Discover the step-by-step process, key improvements, and valuable insights that led to the company obtaining CE mark in a shorter time period.
Download the Case Study
View other our other resources and company news
CAPA Strengthening CAPA & Exceptions Management
Blog EU GMP Annex 1 vs FDA Aseptic Guide: Bridging Compliance
Blog GMP & GDP: Ensuring Quality in Drug Storage and Transport
Blog Blockchain for GMP Documentation: Hype or Future Reality?
Guide Is Your Insurance Policy Ready for the New EU Product Liability Directive?
Article 100% Drug Tariffs in the U.S. – Impact on Pharma Supply Chains & Compliance
Blog Data Governance & AI in Pharma | Ensuring Trust & Compliance
Case Study Global Audit Management for Pharma Company
Blog 